| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/26/2007 | WO2007016159A3 Gat2 transporters expressed in blood brain barrier cells |
| 07/26/2007 | WO2007014372A3 Compositions and methods for treating bacteria |
| 07/26/2007 | WO2006138562A3 Epitope analogues |
| 07/26/2007 | WO2006132670A3 Auristatins having an aminobenzoic acid unit at the n terminus |
| 07/26/2007 | WO2006127910A3 Glycopegylated erythropoietin formulations |
| 07/26/2007 | WO2006119170A3 Use of cytokine-derived peptides in treatment of pain and neurodegenerative disease |
| 07/26/2007 | WO2006107946A3 Bone cement compositions and the like comprising an rnaiii-inhibiting peptide |
| 07/26/2007 | WO2006102728A3 Inclusion compounds of dioclein, floranol or analogs with cyclodextrin and their use for treating cardiovascular diseases |
| 07/26/2007 | WO2006102461A3 Influenza therapeutic |
| 07/26/2007 | WO2006078464A3 Formulations of peptides for periodontal and dental treatments |
| 07/26/2007 | WO2006063596A8 A composition comprising pp for the treatment of gastrointestinal disorders |
| 07/26/2007 | WO2003062448A3 Sqv nucleic acids and polypeptides |
| 07/26/2007 | WO2003053220A3 Compositions and methods for the therapy and diagnosis of inflammatory bowel disease |
| 07/26/2007 | WO2002038600A9 C. elegans genes involved in viability and/or reproduction and uses thereof |
| 07/26/2007 | US20070174926 Sperm factor oscillogenin |
| 07/26/2007 | US20070174922 Nucleic acid encoding novel type-1 cytokine receptor glm-r |
| 07/26/2007 | US20070173636 Reacting a peptide acyl donor comprising a peptidic backbone made up of two or more amino acids with a peptide amine acceptor under reducing reaction conditions employing an excess of a reducing agent; |
| 07/26/2007 | US20070173542 Peptide deformylase inhibitors |
| 07/26/2007 | US20070173515 Delta opioid receptor agonist compounds |
| 07/26/2007 | US20070173471 Morphogen compositions and methods of use thereof to treat heart disorders |
| 07/26/2007 | US20070173466 Methods of treating inflammatory diseases associated with bone destruction |
| 07/26/2007 | US20070173458 Neo-tryptophan |
| 07/26/2007 | US20070173457 Tau-conotoxin peptides |
| 07/26/2007 | US20070173456 Preptin fragments and methods of use |
| 07/26/2007 | US20070173455 Peptide fragments and optionally excipients, used for prophylaxis of obesity and non-insulin dependent diabetes; antagonist of glucose-dependent insulinotropic polypeptide (GIP) consisting of a 24 amino acid polypeptide corresponding to positions 7-30 of the sequence of GIP |
| 07/26/2007 | US20070173454 Administering an agent that decreases or regulates the blood level, production, function or activity of gonadotropins-leutinizing hormone, follicle stimulating hormone, activin or follistatin; parkinson's disease |
| 07/26/2007 | US20070173453 Methods of preventing or treating brain ischemia or brain injury |
| 07/26/2007 | US20070173452 Use of glp-1 analogs and derivatives administered peripherally in regulation of obesity |
| 07/26/2007 | US20070173451 Methods of using soluble heterodimeric cytokine receptor |
| 07/26/2007 | US20070173450 Process for the synchronization of ovulation for timed breeding without heat detection |
| 07/26/2007 | US20070173449 Method of Protection from Ischemic Disease |
| 07/26/2007 | US20070173448 Solution for removing cataracts via liquefracture |
| 07/26/2007 | US20070173447 Method for treating osteoporosis by intranasal delivery of teriparatide with an anti-resorptive agent |
| 07/26/2007 | US20070173446 Administering porcine B-domainless factor VIII (OBI-1) to patient having factor VIII deficiency using recombinant B-domainless porcine fVIII, which has greater bioavailability compared to the natural porcine fVIII partially purified from porcine plasma, termed HYATE:C; hemophilia treatment |
| 07/26/2007 | US20070173445 Methods for treating viral infection using il-28 and il-29 |
| 07/26/2007 | US20070173444 Peptides and compounds that bind to the il-5 receptor |
| 07/26/2007 | US20070173443 polypeptides that induce apoptosis of cancer cells that contain mutant p53 or over-expressed wild-type p53 |
| 07/26/2007 | US20070173442 Combination therapy with glatiramer acetate and mitoxantrone for the treatment of multiple schlerosis |
| 07/26/2007 | US20070173441 Inhibitors of n ethymalemide sensitive factor |
| 07/26/2007 | US20070173440 Methods and pharmaceutical compositions for the treatment and prevention of hepatitis C infection |
| 07/26/2007 | US20070173439 Administering formulation comprising polypeptide and muteins, fused proteins, muteins, functional derivatives and active fragments for treating autoimmune diseases, Type I diabetes, rheumatoid arthritis, graft rejections, inflammatory bowel disease, sepsis, multiple sclerosis, ischemic heart disease etc. |
| 07/26/2007 | US20070173438 [PSI[CH2NH]PG4] glycopeptide antibiotic analogs |
| 07/26/2007 | US20070173437 Bisubstrate inhibitors of protein tyrosine kinases as therapeutic agents |
| 07/26/2007 | US20070173436 Compositions and methods for enhancing drug delivery across and into epithelial tissues |
| 07/26/2007 | US20070173435 Hemoglobin solution packaged in an oxygen and water vapor impermeable flexible container with a multi-layer film having at least a product contact layer, an oxygen and moisture barrier layer and an exterior layer for storage and preservation of deoxygenated hemoglobin solution |
| 07/26/2007 | US20070173434 Antidiabetic oxazolidinediones and thiazolidinediones |
| 07/26/2007 | US20070172946 Lineage specific cells and progenitor cells |
| 07/26/2007 | US20070172923 Homogeneous preparations of il-28 and il-29 |
| 07/26/2007 | US20070172920 Immunoconjugates and humanized antibodies specific for b-cell lymphoma and leukemia cells |
| 07/26/2007 | US20070172915 Glycoprotein synthesis |
| 07/26/2007 | US20070172909 Non-ribosomal peptide synthetases and associated biosynthetic genes |
| 07/26/2007 | US20070172893 Recombinant platelet collagen receptor glycoprotein vi and its pharmaceutical use |
| 07/26/2007 | US20070172892 Novel polypeptide esdn, polynucleotides encoding the polypeptide, and utility of the polypeptide |
| 07/26/2007 | US20070172889 Human Zven polypeptides |
| 07/26/2007 | US20070172880 Transient Receptor Potential Channels is an emerging class of Ca2+-permeable cation channel superfamily; for diagnosis, treatment, and/or prevention of various diseases |
| 07/26/2007 | US20070172849 Detection of markers in nascent proteins |
| 07/26/2007 | US20070172830 Antibodies to hhpen62 polypeptide |
| 07/26/2007 | US20070172827 Multiplex detection probes |
| 07/26/2007 | US20070172811 Preserving hypoxic tissue |
| 07/26/2007 | US20070172517 Compositions capable of facilitation penetration across a biological barrier |
| 07/26/2007 | US20070172516 Increasing of the resorption of substances via skin and mucous membranes |
| 07/26/2007 | US20070172515 Film bandage for mucosal administration of actives |
| 07/26/2007 | US20070172509 Drug Delivery System for Retarding Release of Water Soluble Drugs |
| 07/26/2007 | US20070172497 BoNT/A PEPTIDES AND METHODS OF PREDICTING AND REDUCING IMMUNORESISTANCE TO BOTULINUM TOXIN THERAPY |
| 07/26/2007 | US20070172496 Conjugates of amyloid proteins as vaccines for amyloid-related diseases |
| 07/26/2007 | US20070172493 12832, a novel human kinase-like molecule and uses thereof |
| 07/26/2007 | US20070172489 Caspase inhibitors, especially caspase 3 inhibitors, for the treatment of influenza |
| 07/26/2007 | US20070172486 used to treat tumor (osteosarcoma or Ewing's sarcoma); restenosis |
| 07/26/2007 | US20070172485 Glycopeptides derived from pancreatic structures, antibodies and applications thereof in diagnostics and therapeutics |
| 07/26/2007 | US20070172480 Recombinant platelet collagen receptor glycoprotein vi and its pharmaceutical use |
| 07/26/2007 | US20070172477 Use of soluble cd14 for treatment of diseases |
| 07/26/2007 | US20070172474 Dairy components effective for fat loss |
| 07/26/2007 | US20070172472 Methods and Systems for Treating Injured Cardiac Tissue |
| 07/26/2007 | US20070172471 Method for identifying an anti- streptococcal agent and its use for treating streptococcal infections |
| 07/26/2007 | US20070172470 Phosphatase regulation of nucleic acid transcription |
| 07/26/2007 | US20070172469 Methods For Inhibiting Viral Replication In Vivo |
| 07/26/2007 | US20070172468 Dietary supplements for reducing cholesterol levels |
| 07/26/2007 | US20070172467 for a disorder of a subject's heart involving loss of cardiomyocytes by administering an amount of an agent effective to cause cardiomyocyte proliferation within the subject's heart; Vitamin D3 Up-Regulated Protein-1; peroxiredoxin |
| 07/26/2007 | US20070172464 Stem cells having increased sensitivity to a chemoattractant and methods of generating and using same |
| 07/26/2007 | US20070172459 modified interferons for use in the treatment and prevention of viral infections, cell proliferative and autoimmune disorders |
| 07/26/2007 | US20070172458 IL-6/IL-6R fusion protein |
| 07/26/2007 | US20070172457 Interleukins-21 and 22 |
| 07/26/2007 | US20070172456 IL-1 zeta, IL-1 zeta splice variants and Xrec2 DNAs and polypeptides |
| 07/26/2007 | US20070172455 Chimeric Interleukin-6 Soluble Receptor/Ligand Protein, Analogs Thereof and Uses Thereof |
| 07/26/2007 | US20070172454 Use of il-6/il-6 chimera in huntington's disease |
| 07/26/2007 | US20070172453 Tolerogenic approach for type 1 diabetes |
| 07/26/2007 | US20070172452 Methods for treating viral infection using il-28 and il-29 |
| 07/26/2007 | US20070172451 Methods for treating viral infection using il-28 and il-29 |
| 07/26/2007 | US20070172450 Modulation of immune response and methods based thereon |
| 07/26/2007 | US20070172449 TNF-alpha VARIANT FORMULATIONS FOR THE TREATMENT OF TNF-alpha RELATED DISORDERS |
| 07/26/2007 | US20070172448 Method for detecting the specificity of activated lymphocyte |
| 07/26/2007 | US20070172447 Agent for preventing and/or treating tissue disruption-accompanied diseases |
| 07/26/2007 | US20070172446 Synthetic chemokine receptor ligands and methods of use thereof |
| 07/26/2007 | US20070172445 Chronic articular inflammation-modulating composition based on collagen-polyvinylpyrrolidone |
| 07/26/2007 | US20070172444 Hair tonics and method of screening the same |
| 07/26/2007 | US20070172436 Nonaqueous ascorbic acid compositions and methods for preparing same |
| 07/26/2007 | US20070172423 Composition and method for modulating vasculogenesis for angiogenesis |
| 07/26/2007 | US20070172422 Exponential pattern recognition based cellular targeting compositions, methods and anticancer applications |
| 07/26/2007 | DE10303229B4 Ambroxol und Inhibitoren des Angiotensin Converting-Enzyms (ACE) umfassende Arzneimittel Arzneimittel-Zubereitung und ihre Verwendung zur Behandlung von neurodegenerativen Erkrankungen Ambroxol and inhibitors of the angiotensin converting enzyme (ACE) pharmaceutical compositions comprising drug preparation and their use for the treatment of neurodegenerative diseases |
| 07/26/2007 | DE102006051941A1 Multifunctional active agent mixture, useful as auxiliary material in virus vaccine or vaccine to treat cancer, comprises fraction of specific peptide in polypetide chain and fraction with essential and non-essential amino acids |